Companies Ramping Up Digital Transformation Plans as Result of COVID-19, Survey Finds
A recent survey by Twilio suggests that a clear majority of companies have sped up their digital transformation plans in [...]
Gao: ‘Misunderstanding of P-values Spells Disaster’
A greater understanding of the p-value could go a long way in trying to combat contradictory health advice, Jian Gao [...]
Impact of Drug Cost Transparency
In the latest installment of the Relentless Health Value podcast, RxRevu CEO and Co-Founder Carm Huntress discusses how greater transparency [...]
Eversana Acquires HVH Precision Analytics to Beef Up Data, Analytics Capabilities
Eversana has acquired HVH Precision Analytics from Havas Health & You in a bid to bolster its data analytics capabilities, [...]
Zemcik, Fry Spotlight CMS Best Price Proposal
Commercial Solutions' Rick Fry and TrialCard's Jason Zemcik spotlight the Centers for Medicare and Medicaid Services' best price proposal in [...]
Research Suggests Pharma Retains Lowest Share of Revenue than Other High R&D Industries
Oxford Economics in a new study suggests the pharmaceutical industry only retains 52 percent of total spending, with the remaining [...]
MSLS Webinar to Highlight Board Certification Program
The Medical Science Liaison Society (MSLS) is set to host a free webinar on the benefits of taking the MSL-Board [...]
Bach Outlines ‘Gaping’ Loophole in Medicaid Proposal
A Centers for Medicare and Medicaid Services proposal includes a "gaping" loophole through which drugmakers could avoid selling drugs to [...]
Raman Offers Primer on U.S. Health System in New Book
Sivakumaran Raman in his latest book offers an overview of the U.S. health care system. "Just Enough Healthcare: A pick-up-and-read-through [...]
Report Spotlights Marketing During COVID-19
A new report from Reuters Events offers guidance for pharmaceutical industry solutions providers looking for fresh insights into marketing strategies [...]
Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD
Excerpt of tHEORetically Speaking blog post sponsored by Veradigm Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic [...]
ISPOR Seeks New Members for Health Science Policy Council
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is searching for three mid-career members for its Health Science Policy [...]
On-Demand Webinar Offers Guidance for Getting Started in MedComms
A recent webinar hosted by NetworkPharma.tv offers guidance for individuals interested in entering a career in the medical communications landscape. [...]
Rubenstein Talks Modern RWD, RWE in Regulatory Decision-Making
FDA Center for Devices and Radiological Health Director of Personalized Medicine Wendy Rubenstein says modern sources of real-world evidence and [...]
FDA Rejects Intercept’s OCA for NASH
The Food and Drug Administration (FDA) last month rejected Intercept Pharmaceuticals' nonalcoholic steatohepatitis (NASH) drug, creating a major delay in [...]
Opinion: Discuss Price for COVID-19 Vaccine Now, Not Later
The U.S. should begin pricing discussions for a COVID-19 vaccine before we get "stuck paying dearly for shots that the [...]
Report Explores Patient Centricity in Clinical Trials
A new report by the Economist Intelligence Unit explores the importance of expanding patient engagement in the clinical trial landscape. [...]
ICER Hosting Series on Drug Pricing During a Pandemic
The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during [...]
Article: Researchers Point to Germany’s Model for Purchasing Cancer Drugs
Researchers say U.S. policymakers should look to Germany's drug purchasing model to try and better align cancer drug prices with [...]
ICER Reschedules CF Meeting
The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. [...]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains [...]
NICE Clinical Fellow Ali Highlights Sustainability Efforts
Fizzah Ali, a medical clinical fellow at the U.K.'s National Institute for Health and Care Excellence, discusses how the Sustainability [...]
ISPOR to Host Webinar on Drug, Device Utilization Amid Pandemic
The International Society for Pharmacoeconomics and Outcomes Research is set to host a July 28 webinar highlighting the COVID-19 pandemic's [...]
Medidata, CTI Partner on Remote Trial Reviews
CTI Clinical Trial Solutions and Consulting Services is partnering with Medidata to facilitate remote monitoring and reviews for clinical trials [...]
Report: European Drug Regulatory Network Faces Uncertain, Complex Future
A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. [...]